Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CTX”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05621759
What this trial is testing

Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD

Who this might be right for
Graft Vs Host Disease
NYU Langone Health 27
Testing effectiveness (Phase 2)Study completedNCT00003388
What this trial is testing

Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma

Who this might be right for
Lymphoma
Eastern Cooperative Oncology Group 38
Not applicableActive Not RecruitingNCT01928589
What this trial is testing

Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer

Who this might be right for
Breast CancerAdenocarcinoma of the Breast
Richard Zellars 81
Not applicableStudy completedNCT05886335
What this trial is testing

Influence of Timing PTCy in AlloSCT

Who this might be right for
Cyclophosphamide ToxicityAllogenic Haematopoetic Transplantation
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 180
Testing effectiveness (Phase 2)UnknownNCT03357159
What this trial is testing

Anti T-lymphocyte Immunoglobulin With Post Transplant Cyclophosphamide to Prevent GVHD Post Allogeneic Transplantation

Who this might be right for
Graft Versus Host Disease
Sheba Medical Center 30
Not applicableUnknownNCT04654195
What this trial is testing

Study of ABCB1,SLC22A16 Drug Transporter Genes and Doxorubicin and Cyclophosphamide Toxicity in Brest Cancer Patient

Who this might be right for
Breast Cancer Patients
Damanhour University 100
Post-approval studies (Phase 4)UnknownNCT03689465
What this trial is testing

PTCy-ATG vs ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis

Who this might be right for
Hematopoietic Stem Cell Transplantation
Nanfang Hospital, Southern Medical University 260
Testing effectiveness (Phase 2)Active Not RecruitingNCT04166565
What this trial is testing

Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease

Who this might be right for
Multiple MyelomaExtramedullary Plasmacytoma
Stichting European Myeloma Network 41
Testing effectiveness (Phase 2)Ended earlyNCT02323230
What this trial is testing

DPX-Survivac Vaccine Therapy in Patients With Recurrent Survivin-expressing DLBCL

Who this might be right for
Diffuse Large B-Cell Lymphoma
ImmunoVaccine Technologies, Inc. (IMV Inc.) 4
Not applicableUnknownNCT04218006
What this trial is testing

A Study on the Prevalence of Mutation of Cerebrotendinous Xanthomatosis (CTX)

Who this might be right for
Xanthomatosis, Cerebrotendinous
TRPHARM 800
Testing effectiveness (Phase 2)Study completedNCT01315132
What this trial is testing

Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies

Who this might be right for
Hematological MalignanciesLeukemiaLymphoma+2 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 47
Testing effectiveness (Phase 2)Study completedNCT01857232
What this trial is testing

Dose-finding Study of APD403 to Prevent Nausea and Vomiting After Chemotherapy

Who this might be right for
CINV
Acacia Pharma Ltd 342
Testing effectiveness (Phase 2)Study completedNCT00574587
What this trial is testing

Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy

Who this might be right for
Breast Cancer
Albert Einstein College of Medicine 55
Testing effectiveness (Phase 2)Study completedNCT00450814
What this trial is testing

Vaccine Therapy With or Without Cyclophosphamide in Treating Patients With Recurrent or Refractory Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Mayo Clinic 48
Testing effectiveness (Phase 2)Study completedNCT00409032
What this trial is testing

A Dose-response Study With Strontium Malonate in Postmenopausal Women

Who this might be right for
Osteoporosis
Osteologix 275
Testing effectiveness (Phase 2)Study completedNCT02217163
What this trial is testing

Carfilzomib, Cyclophosphamide, Dexamethasone in Transplant Eligible Newly Diagnosed High-risk Multiple Myeloma

Who this might be right for
Multiple Myeloma
Singapore General Hospital 30
Not applicableNot Yet RecruitingNCT06652152
What this trial is testing

Mechanism Investigation of R-CHOP Regimen or Tucidinostat Plus R-CHOP (CR-CHOP) Regimen in the Treatment of BCL2/MYC Protein Double Expressor Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)Double Expressor Lymphoma
Ruijin Hospital 400
Large-scale testing (Phase 3)Looking for participantsNCT04061512
What this trial is testing

Rituximab and Ibrutinib (RI) Versus Dexamethasone, Rituximab and Cyclophosphamide (DRC) as Initial Therapy for Waldenström's Macroglobulinaemia

Who this might be right for
Waldenstrom Macroglobulinemia
University College, London 148
Large-scale testing (Phase 3)UnknownNCT06324266
What this trial is testing

Study on the Efficacy and Safety of Low-dose CTX as Maintenance Therapy for MM Unsuitable for Transplantation

Who this might be right for
Newly Diagnosed Multiple Myeloma
Jinling Hospital, China 80
Early research (Phase 1)Active Not RecruitingNCT04231877
What this trial is testing

Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma

Who this might be right for
Aggressive Non-Hodgkin LymphomaALK-Positive Large B-Cell LymphomaDiffuse Large B-Cell Lymphoma, Not Otherwise Specified+6 more
University of Washington 56
Next Page